Jiangsu Haici Biological Pharmaceutical Co., Ltd., a wholly-owned subsidiary invested by Yangtze River Pharmaceutical Group in 2004, is located in 8 Taizhen Road, Medical New & Hi-tech Industrial Development Zone. It is the group's chemical raw material drug research and development, pilot test and production base. It covers an area of more than 460 acres, with a total investment of 1.7 billion yuan and more than 700 employees. Mainly committed to the technical research, production and sales of high value-added APIs and pharmaceutical intermediates, and extensively carry out foreign cooperation in the fields of innovative drugs CDMO/CMO, drug agency sales and other fields.
Founded in
Total area
Existing employees
Enterprise Honor
On February 26, Yangtze River Pharmaceutical Group held the 45th "Quality Brand · Safety and Environmental Protection Month" event...
Recently, the website of the Jiangsu Provincial Department of Culture and Tourism issued the "Notice on the Recognition Results of Prov...
At the year-end work conference held on December 31, 2020, Xu Jingren, Party Secretary and Chairman of Yangtze River Pharmaceutical Group, p...